HETA MEHTA
** *, ***** ******, ******, MA-*****.
https://www.linkedin.com/in/hetamehta
*****.**@*****.***.*** 857-***-****
EDUCATION
Northeastern University Boston, MA
Candidate for Master’s in Regulatory Affairs for Drugs, Medical Devices and Biologics GPA: 4.00/4.00 July, 2017
Relevant Coursework: New Drug Development, New Biologics Development, New Medical Devices Development, Human Experimentation, Clinical trial design optimization and problem solving Institute of Chemical Technology Mumbai, India
Bachelor’s in Pharmaceutical Sciences
GPA: 7.51/10.00 May, 2015
Activities: Member of Student Council, Literary Club, Art Club WORK EXPERIENCE
IPCA Pvt. Ltd. Mumbai, India
Apprentice Trainee May 2014 - July 2014
Assisted the product development officer in the Chemical Synthesis Research and Development department
Observed and understood the process of New Drug Development
Reviewed, compiled and recorded analytical testing data in the company database
Supported in analytical testing of the product using High Pressure Liquid Chromatography (HPLC), Gas Chromatography (GC) and Mass Spectrophotometer
MEHTA API Pvt. Ltd. Mumbai, India
Intern May 2013 - July 2013
Assisted in the quality control department with quality testing of Active Pharmaceutical Ingredients
Acquired the knowledge of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP)
Reviewed the SOPs and tested products so as comply with the U.S., Indian or the British Pharmacopoeia
Analyzed the test results as per required specifications and documented them in the company database
Utilized U.V Spectrophotometer, Karl Fischer titration apparatus for analytical testing of drug product ACADEMIC PROJECTS
Mock Biosimilar Development Plan
Northeastern University, Spring 2015
Developed a biosimilar product development plan was per the section 351(k) of the PHS Act, considering all the FDA regulations and guidelines.
Mock Premarket Notification 510 (k) submission
Northeastern University, Fall 2015
Fabricated a 510 (k) premarket notification submission for the device SpyGlass DS Direct Visualization System that involved classification, demonstration of substantial equivalence and listing requirements as per 21 CFR 807 Regulatory Plan Development
Northeastern University, Fall 2015
Designed a Clinical and Regulatory Development Plan for the drug Indinavir Sulphate. Analyzed the drug and proposed a regulatory plan with an intention to market the drug in compliance with the FDA laws and regulations Buprenorphine: As a long term injectable
Institute of Chemical Technology, 2015
Hypothesized a novel drug delivery system for Buprenorphine; an analgesic drug Physical methods for gene delivery: Its limitations and solutions to resolve them Institute of Chemical Technology, 2014
Wrote a review paper on the physical techniques for gene delivery and proposed solutions to resolve the problems SKILLS
Computer Systems: Microsoft Word, Microsoft Excel, Microsoft PowerPoint, Adobe Acrobat Additional Skills: Acquaintance to ICH guidelines, Clinical protocol writing, Couch consent forms, Understanding of IND, NDA, ANDA, BLA, PMA and 510(k), Quality System Regulations, FAERS and AE reporting, eCTD, eTMF, Research/Investigating, Technical writing, Editing, Strategizing.